AXA Investment Managers

Latour Capital, established in 2011, is a French private equity firm headquartered in Paris. It specializes in buyout investments, focusing on small and mid-sized companies across Europe, with a particular interest in the networking, manufacturing, industrial, and commercial services sectors. The firm typically invests in companies valued between EUR 50 million to EUR 200 million, providing majority or minority stakes. Latour Capital works closely with management teams to develop businesses and create value for all stakeholders, leveraging the entrepreneurial spirit and operational knowledge of its investment professionals.

Capza, established in 2004, is a European private investment platform headquartered in Paris, France. It specializes in providing flexible equity and private debt financing to small and mid-cap companies across various sectors, with a focus on healthcare, software, IT services, and e-commerce. Capza manages €2.7 billion in assets and offers four complementary areas of expertise: Flex Equity, Private Debt, Transition, and Artemid Senior Loans. The company is majority-owned by its teams and supported by the AXA Group, with the management team holding a 54% stake. Capza's investment strategy targets companies with an EBITDA range of €2 million to €10 million, aiming to support their growth and development.

Rivage Investment is an independent asset management company established in 2010 and headquartered in Paris, France. The firm specializes in asset and investment management solutions, focusing on private debt and equity derivatives, as well as providing advisory services. Rivage Investment leverages its expertise in European infrastructure and French public sector debt financing to target investments in key sectors, including renewable energy, transport, waste management, telecommunications, and public sector entities such as local authorities, public hospitals, and social housing. The firm is dedicated to combating global warming and has a proven history of financing projects that promote energy transition.

Switchee Limited, founded in 2014 and based in London, specializes in developing connected devices and analytics aimed at landlords and their residents. The company is recognized as a leader in the Internet of Things (IoT) for social housing in the UK, offering an innovative smart thermostat that optimizes the management of heating and hot water in homes. This device not only reduces energy bills but also acts as a two-way communication platform with residents, enabling landlords to address maintenance issues and improve communication effectively. By leveraging real-time data, Switchee helps landlords manage their property portfolios more efficiently, ensuring better living conditions while also contributing to cost savings for both landlords and residents. The company’s solutions play a crucial role in combating fuel poverty and addressing issues related to damp and mould, enhancing the overall quality of housing management.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in developing solutions for urinary incontinence and chronic fecal incontinence, conditions that are often underreported. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic that provides at-home treatment options. Utilizing patented technology, the system offers non-invasive and drug-free solutions by providing real-time visualization of pelvic floor movements while monitoring progress and usage. This approach enables women to effectively strengthen their pelvic floor muscles and alleviate symptoms associated with various types of incontinence, including stress, mixed, and urgency incontinence.

Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors for health monitoring. Founded in 2012, Biolinq focuses on creating a digital health platform that offers minimally invasive electrochemical biosensors. These sensors analyze biomarkers in interstitial fluid to deliver actionable health information, particularly for diabetic patients who need to monitor their blood glucose levels. By enabling continuous monitoring of multiple biomarkers, the company's technology aims to improve metabolic health and provide a more convenient alternative to traditional blood glucose monitoring methods.

Iceberg Data Lab is a financial technology company that specializes in providing environmental data solutions for financial institutions. The company develops assessment tools and methodologies designed to calculate the environmental impacts of issuers and assets across the entire value chain, from supply chain to end-use. By offering these solutions, Iceberg Data Lab enables financial companies to effectively report and manage their environmental impact, allowing them to assess the sustainability of their portfolios.

W Capital Partners, established in 2001, is a New York-based private equity firm specializing in secondary investments. It provides liquidity solutions to private company shareholders and other investment firms, focusing on business services, healthcare, and technology sectors across the U.S. and Europe. The firm offers tailored solutions, structuring transactions ranging from $5 to $250 million, and also invests primary capital to support portfolio company growth. W Capital invests across late-stage venture capital, growth equity, and buyout stages, with a diversified portfolio construction approach across various industry sectors.

LimmaTech Biologics is a clinical-stage biotech company focused on developing vaccines to prevent life-threatening diseases. It specializes in creating bioconjugate vaccines through innovative techniques such as glycoengineering and protein glycosylation, which improve the efficiency of vaccine development and address challenges associated with traditional chemical conjugation methods. The company's proprietary self-adjuvanting and multi-antigen vaccine platforms target microbial infections that are increasingly resistant to existing treatments. LimmaTech Biologics is dedicated to expanding its pipeline, aiming to provide effective solutions for infectious diseases that currently have limited treatment options. Through its research and development efforts, the company seeks to enhance healthcare outcomes by delivering tailored vaccines for specific pathogens.

LimmaTech Biologics is a clinical-stage biotech company focused on developing vaccines to prevent life-threatening diseases. It specializes in creating bioconjugate vaccines through innovative techniques such as glycoengineering and protein glycosylation, which improve the efficiency of vaccine development and address challenges associated with traditional chemical conjugation methods. The company's proprietary self-adjuvanting and multi-antigen vaccine platforms target microbial infections that are increasingly resistant to existing treatments. LimmaTech Biologics is dedicated to expanding its pipeline, aiming to provide effective solutions for infectious diseases that currently have limited treatment options. Through its research and development efforts, the company seeks to enhance healthcare outcomes by delivering tailored vaccines for specific pathogens.

Enough is a technology spin-out from the University of Strathclyde focused on the development and commercialization of innovative mycoprotein-based food products. The company aims to enhance the sustainability of protein production by integrating its manufacturing processes into existing bio-refinery operations that produce bio-ethanol and animal feed. This approach not only optimizes the production of food but also contributes to a circular economy by utilizing resources efficiently. Enough's products are designed to be environmentally friendly, utilizing less water and generating lower carbon dioxide emissions. The fermentation process employed is zero-waste, resulting in food ingredients that provide all essential amino acids and are high in dietary fiber, making them viable substitutes for meat at a low cost.

Meva Energy, founded in 2008 and based in Sweden, specializes in gasification technology aimed at generating renewable energy from small fraction fuels. The company focuses on biomass gasification, which allows for the production of power and heat energy. This technology is utilized in various applications, including heating buildings, melting materials, operating engines, and boiling water. By enabling clients to harness sustainable power and heat, Meva Energy contributes to improved profitability and environmental sustainability in energy production.

Finerge is a renewable energy producer dedicated to offering sustainable and clean energy solutions. The company focuses on the development, construction, and acquisition of wind farms and photovoltaic solar plants. With operations in over 46 municipalities across Portugal and three provinces in Spain, Finerge harnesses wind energy and utilizes thousands of photovoltaic modules to generate clean electricity. By expanding access to renewable energy sources, Finerge plays a significant role in the transition to more sustainable energy practices.

Mombak is a carbon removal company dedicated to reforesting the Amazon. It specializes in cultivating native, biodiverse forests that effectively remove carbon from the atmosphere while ensuring high integrity in its projects. The company's initiatives are designed to achieve significant additionality and durability, with minimal leakage, thus enhancing biodiversity and supporting socioeconomic development in local communities. Mombak's team consists of experts in science, technology, forestry, and carbon markets, all working together to improve forestry practices and contribute to a sustainable future.

Helium Health is a technology company focused on transforming healthcare in Africa by providing a comprehensive suite of software solutions for hospitals and clinics. The company specializes in electronic health record systems that facilitate the management of patient data and hospital operations. Its platform simplifies various processes, including doctor visits, prescriptions, and medical billing, making it accessible from any device. Additionally, Helium Health offers customizable forms and tools for monitoring healthcare trends, generating alerts, and producing reports. By leveraging technology, the company aims to create a modern and affordable healthcare system while aspiring to become the largest healthcare data exchange in Africa.

Chloris Geospatial specializes in innovative remote sensing technology aimed at monitoring natural resources and addressing critical natural capital issues. The company employs advanced methods that combine remote sensing, machine learning, and ecological science to accurately measure carbon stocks, as well as gains and losses, while quantifying uncertainty. Their sensor fusion technology provides insights at a global scale and with high accuracy, equipping clients with essential measurements of natural capital. This enables organizations to tackle pressing global climate challenges and other natural crises effectively.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in developing solutions for urinary incontinence and chronic fecal incontinence, conditions that are often underreported. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic that provides at-home treatment options. Utilizing patented technology, the system offers non-invasive and drug-free solutions by providing real-time visualization of pelvic floor movements while monitoring progress and usage. This approach enables women to effectively strengthen their pelvic floor muscles and alleviate symptoms associated with various types of incontinence, including stress, mixed, and urgency incontinence.

Ophirex is focused on developing a groundbreaking drug aimed at treating snakebite victims, addressing a critical health issue that results in approximately 500,000 deaths or amputations each year. With 70% of these fatalities occurring before patients reach medical facilities, Ophirex's innovative oral formulation offers a significant advancement in emergency care. The drug is a small molecule inhibitor specifically designed to target the most lethal components of snake venom, making it effective against a range of dangerous snake species. This antidote is intended for both human and veterinary use, providing a safe and accessible initial treatment option for snakebite envenoming in field settings, where the majority of bites take place.

CleanFiber, LLC specializes in producing high-performance cellulose insulation materials made from recycled corrugated cardboard for residential and commercial construction. Founded in 2013 and based in Blasdell, New York, with an additional office in Buffalo, CleanFiber transitioned from its previous name, UltraCell Insulation, in September 2018. The company focuses on providing sustainable, carbon-negative insulation solutions that can be applied in attics, walls, and floors, catering to both new construction and retrofit projects. CleanFiber's products not only enhance fire resistance in buildings but also offer a cost-competitive alternative for construction companies, supporting environmentally friendly building practices. The company is currently expanding its production capabilities to meet growing demand.

Eyenuk, Inc. is a medtech company focused on developing artificial intelligence-based technology for retinal image analysis and disease detection. Founded in 2010 and based in Woodland Hills, California, Eyenuk's flagship product, the EyeArt AI Eye Screening System, is recognized for its extensive validation in the autonomous detection of diabetic retinopathy. The company also offers solutions such as EyeMark, which tracks retinopathy progression, and EyeApp, a mobile application that allows healthcare providers to conduct diabetic retinopathy screenings using smartphones. Additionally, Eyenuk provides EyeSeeAMD, a technology for identifying age-related macular degeneration. The company's mission is to screen every eye globally to ensure timely diagnosis of potentially life-threatening eye diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration, among others.

Switchee Limited, founded in 2014 and based in London, specializes in developing connected devices and analytics aimed at landlords and their residents. The company is recognized as a leader in the Internet of Things (IoT) for social housing in the UK, offering an innovative smart thermostat that optimizes the management of heating and hot water in homes. This device not only reduces energy bills but also acts as a two-way communication platform with residents, enabling landlords to address maintenance issues and improve communication effectively. By leveraging real-time data, Switchee helps landlords manage their property portfolios more efficiently, ensuring better living conditions while also contributing to cost savings for both landlords and residents. The company’s solutions play a crucial role in combating fuel poverty and addressing issues related to damp and mould, enhancing the overall quality of housing management.

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the chemokine receptor CXCR4, currently undergoing multiple clinical trials. These include a Phase III trial for patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, as well as Phase Ib and Phase IIa trials focused on severe congenital neutropenia and clear cell renal cell carcinoma, respectively. In addition, X4 Pharmaceuticals is advancing X4P-002, targeting glioblastoma multiforme, and X4P-003 aimed at primary immune deficiencies. The company has also established a license agreement with Abbisko Therapeutics to develop mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.

MFS Africa is the largest mobile money inter-operability hub in Africa, which connects mobile network operators across the continent through a single API. In addition to mobile remittance services, the MFS Africa API enables merchant payment, bulk payment, bank-to-wallet transfers, and an array of other cross border digital payments services.

Carbon Clean Solutions, established in 2009, specializes in carbon dioxide (CO2) separation technology for industrial applications. Based in Mumbai, India, with operations and research facilities in the UK, India, and the US, the company offers proprietary technologies such as CDRMax, Meth Pure, and CCS TGR to capture and recover CO2 from various industrial processes, including power plants, steel, cement, fertilizer, chemical, and petrochemical industries. Their patented, energy-efficient APBS CO2 capture process enables up to 90% CO2 removal, reducing emissions and providing industrial-quality CO2 for reuse or sequestration.

Sistema.bio is a manufacturer of prefabricated modular biodigester systems aimed at enhancing the efficiency and quality of life for small farmers. The company's systems utilize anaerobic bacteria to convert manure and various organic waste types into methane gas and organic fertilizer. This biogas can be harnessed for thermal energy used in cooking and generating electricity, while the fertilizer supports agricultural productivity. By transforming organic waste into valuable resources, Sistema.bio enables farmers to turn a potential problem into opportunities for increased productivity and sustainability.

Enough is a technology spin-out from the University of Strathclyde focused on the development and commercialization of innovative mycoprotein-based food products. The company aims to enhance the sustainability of protein production by integrating its manufacturing processes into existing bio-refinery operations that produce bio-ethanol and animal feed. This approach not only optimizes the production of food but also contributes to a circular economy by utilizing resources efficiently. Enough's products are designed to be environmentally friendly, utilizing less water and generating lower carbon dioxide emissions. The fermentation process employed is zero-waste, resulting in food ingredients that provide all essential amino acids and are high in dietary fiber, making them viable substitutes for meat at a low cost.

PackBenefit is a European company that specializes in high-performance fiber-based food packaging. It designs and manufactures recyclable and compostable cellulose trays, catering to the commercial food industry, including fresh food and food-to-go markets. The company offers a variety of products, such as trays, films, and sealers, all produced using its patented thermoforming-coating production process. By focusing on ecological packaging solutions, PackBenefit provides clients with viable alternatives to traditional plastic packaging, promoting sustainability in the food sector.

Sanergy, established in 2010, operates in Nairobi, Kenya, focusing on providing affordable and accessible sanitation solutions in urban slums. The company constructs and franchises low-cost sanitation centers offering toilets and hot showers, which are financed through local microfinance banks. Sanergy collects and processes human waste daily, converting it into biogas for electricity generation and organic fertilizer for sale to farms. Additionally, it collects organic waste from local businesses, transforming it into insect-based animal feed. By creating a circular economy, Sanergy promotes hygiene, reduces environmental pollution, and empowers local entrepreneurs.

Eyenuk, Inc. is a medtech company focused on developing artificial intelligence-based technology for retinal image analysis and disease detection. Founded in 2010 and based in Woodland Hills, California, Eyenuk's flagship product, the EyeArt AI Eye Screening System, is recognized for its extensive validation in the autonomous detection of diabetic retinopathy. The company also offers solutions such as EyeMark, which tracks retinopathy progression, and EyeApp, a mobile application that allows healthcare providers to conduct diabetic retinopathy screenings using smartphones. Additionally, Eyenuk provides EyeSeeAMD, a technology for identifying age-related macular degeneration. The company's mission is to screen every eye globally to ensure timely diagnosis of potentially life-threatening eye diseases, including diabetic retinopathy, glaucoma, and age-related macular degeneration, among others.

Alydia Health, Inc. is a medical device company based in Menlo Park, California, focused on addressing postpartum hemorrhage (PPH), a leading cause of maternal mortality. The company designs and manufactures the Jada System, a device that effectively stops excessive bleeding by promoting natural uterine contractions after childbirth. This innovative solution utilizes a vacuum-induced tamponade effect, enabling the body to control postpartum hemorrhage without the need for pharmaceuticals or surgical interventions. Founded in 2010 and rebranded from InPress Technologies in 2018, Alydia Health aims to significantly enhance the treatment options for PPH, ultimately improving the health outcomes of women globally and reducing healthcare costs associated with maternal care.

Komaza is a tech-driven sustainable forestry company focused on transforming the wood industry in Africa through its innovative farmer platform. Founded in 2006 by Tevis Howard, the company engages rural farmers to cultivate woodlots on small-holder farms, addressing the growing demand for wood and wood products. By integrating technology, training, and support, Komaza aims to provide a sustainable wood supply while achieving significant cost savings compared to traditional plantations. This approach not only helps alleviate the wood supply crisis but also empowers farmers to maximize their potential in the forestry sector.

Acciona is a leading Spanish corporation specializing in sustainable solutions for infrastructure and renewable energy projects. Established over a century ago, it employs more than 30,000 people and operates in over 30 countries across five continents. The company is structured into two main divisions: energy and infrastructure. The energy division emphasizes renewable technologies, focusing on wind, solar, hydro, and biomass, while the infrastructure division includes construction, water treatment, and various service lines. Acciona undertakes projects through government concessions or independent opportunities, ensuring a commitment to sustainability through its Sustainability Master Plan, which aims to facilitate the transition to a low-carbon economy by optimizing resource use and minimizing environmental impact.

Dreams is a Neo-bank based in Stockholms Lan, Sweden, founded in 2013. The company operates a mobile application designed to simplify saving, spending, and lending money, making these financial activities more engaging and social for users. The app serves as a personal trainer for users' finances, providing motivation and support to help them achieve their savings goals. By breaking down larger financial objectives into manageable steps, Dreams empowers individuals to save for various aspirations, ultimately making their dreams more attainable.

Kley Group is a prominent French platform specializing in student housing, recognized for having the largest owner-operator portfolio in the sector. The company develops and operates student housing facilities, offering a range of accommodations including studio, duet, and shared apartments. Kley Group focuses on creating environments that foster community and collaboration among students, providing common spaces designed for work-related activities and social interaction. By prioritizing modern living needs, Kley Group enables students in France to find housing that suits their preferences and enhances their overall educational experience.

SFR operates as a mobile telecommunications operator in France. The company offers mobile telephony services on post paid basis, and prepaid basis through phone cards; mobile multimedia services, such as music, television, video, and games; and data transmission services for residential, professional, and corporate customers. It also operates in the fixed-line telecommunication sector, including voice, data transmission, and broadband Internet access. The company was founded in 1987 and is based in Paris, France. SFR operates as a subsidiary of Vivendi.

Dreams is a Neo-bank based in Stockholms Lan, Sweden, founded in 2013. The company operates a mobile application designed to simplify saving, spending, and lending money, making these financial activities more engaging and social for users. The app serves as a personal trainer for users' finances, providing motivation and support to help them achieve their savings goals. By breaking down larger financial objectives into manageable steps, Dreams empowers individuals to save for various aspirations, ultimately making their dreams more attainable.

Roxy is a female sports fashion clothing brand based in Costa Mesa, California, specializing in a variety of apparel and accessories. The brand offers an extensive online shop where customers can purchase clothing items such as dresses, tops, tees, tanks, hoodies, jackets, and loungewear, as well as swimwear, shoes, and a range of accessories including handbags, backpacks, hats, and gloves. Roxy focuses on providing a diverse selection of products to meet the needs and budgets of its customers, catering to those interested in sports and active lifestyles.